Mersana Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 123
- Market Cap
- $191.3M
- Website
- http://www.mersana.com
A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Small Cell Lung CancerNon-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2007-04-03
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- Mersana Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT00455052
- Locations
- 🇺🇸
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
🇺🇸University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Evergreen Hematology & Oncology, Spokane, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath